Genetic reduction of Nrf2 exacerbates cognitive deficits in a mouse model of Alzheimer’s disease
Open accessThe DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Abstract
Aging is the major risk factor for several neurodegenerative diseases, including Alzheimer's disease (AD). However, the mechanisms by which aging contributes to neurodegeneration remain elusive. The nuclear factor (erythroid-derived 2)-like 2 (Nrf2) is a transcription factor that regulates expression of a vast number of genes by binding to the antioxidant response element. Nrf2 levels decrease as a function of age, and reduced Nrf2 levels have been reported in postmortem human brains and animal models of AD. Nevertheless, it is still unknown whether Nrf2 plays a role in the cognitive deficits associated with AD. To address this question, we used a genetic approach to remove the Nrf2 gene from APP/PS1 mice, a widely used animal model of AD. We found that the lack of Nrf2 significantly exacerbates cognitive deficits in APP/PS1, without altering gross motor function. Specifically, we found an exacerbation of deficits in spatial learning and memory, as well as in working and associative memory. Different brain regions control these behavioral tests, indicating that the lack of Nrf2 has a global effect on brain function. The changes in cognition were linked to an increase in Aβ and interferon-gamma (IFNγ) levels, and microgliosis. The changes in IFNγ levels are noteworthy as previously published evidence indicates that IFNγ can increase microglia activation and induce Aβ production. Our data suggest a clear link between Nrf2 and AD-mediated cognitive decline and further strengthen the connection between Nrf2 and AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Indeed, impairment of Nrf2 function worsened cognitive defects in a mouse model of AD90, suggesting the importance of the Nrf2 system in AD.”
From Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease (2019) · cites this paper as [90]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: p62 improves AD-like pathology by increasing autophagy
Caccamo, A., Ferreira, E., Branca, C., & Oddo, S. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.139 · Cited by 109 · cited 1×
“To conduct this test, we used the proteasomal substrates, SucLLVY-AMC, Bz-VGR-AMC, and Z-LLE-AMC (Enzo Life Sciences, PA, USA), as previously described (77).”
MethodSelf-citationRetracted2016 Alzheimer's disease facts and figures
Alzheimer's Association (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.03.001 · Cited by 5,069
Querfurth, H. W., & LaFerla, F. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0909142 · Cited by 4,569
Itoh, K., Chiba, T., Takahashi, S., Ishii, T., Igarashi, K., Katoh, Y., Oyake, T., Hayashi, N., Satoh, K., Hatayama, I., et al. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6943 · Cited by 3,999
Itoh, K., Wakabayashi, N., Katoh, Y., Ishii, T., Igarashi, K., Engel, J. D., & Yamamoto, M. (1999) · Genes & Development · doi:10.1101/gad.13.1.76 · Cited by 3,634
Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease
Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T., & Hyman, B. T. (1992) · Neurology · doi:10.1212/wnl.42.3.631 · Cited by 2,668 · cited 2×
“mTOR is one of the major negative regulators of autophagy, and its activity is increased in AD (25,36,37).”
BackgroundThe Nrf2 regulatory network provides an interface between redox and intermediary metabolism
Hayes, J. D., & Dinkova-Kostova, A. T. (2014) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2014.02.002 · Cited by 2,141 · cited 2×
“To confirm the lack of the Nrf2 gene functionally, we measured heme oxygenase 1 (HO-1) levels by western blot, as HO-1 is an essential Nrf2 target gene (3).”
BackgroundMethodWidespread Peroxynitrite-Mediated Damage in Alzheimer’s Disease
Smith, M. A., Richey Harris, P. L., Sayre, L. M., Beckman, J. S., & Perry, G. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02653.1997 · Cited by 1,239
Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer’s disease
Giannakopoulos, P., Herrmann, F. R., Bussière, T., Bouras, C., Kövari, E., Perl, D. P., Morrison, J. H., Gold, G., & Hof, P. R. (2003) · Neurology · doi:10.1212/01.wnl.0000063311.58879.01 · Cited by 1,118 · cited 2×
“mTOR is one of the major negative regulators of autophagy, and its activity is increased in AD (25,36,37).”
BackgroundOxidative stress response and Nrf2 signaling in aging
Zhang, H., Davies, K. J. A., & Forman, H. J. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.05.036 · Cited by 804 · cited 2×
“Reduced Nrf2 activity is linked to aging and agedependent neurodegenerative diseases (11).”
BackgroundCampion, D., Dumanchin, C., Hannequin, D., Dubois, B., Belliard, S., Puel, M., Thomas-Anterion, C., Michon, A., Martin, C., Charbonnier, F., et al. (1999) · The American Journal of Human Genetics · doi:10.1086/302553 · Cited by 785
Oxidative Alterations in Alzheimer's Disease
Markesbery, W. R., & Carney, J. M. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00215.x · Cited by 784
Suh, J. H., Shenvi, S. V., Dixon, B. M., Liu, H., Jaiswal, A. K., Liu, R.-M., & Hagen, T. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400282101 · Cited by 772 · cited 2×
“ity decreases as a function of age (32,35).”
BackgroundAl-Atrache, Z., Cader, A., & Appelt, D. M. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.06.894 · Cited by 765
Expression of Nrf2 in Neurodegenerative Diseases
Ramsey, C. P., Glass, C. A., Montgomery, M. B., Lindl, K. A., Ritson, G. P., Chia, L. A., Hamilton, R. L., Chu, C. T., & Jordan-Sciutto, K. L. (2007) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/nen.0b013e31802d6da9 · Cited by 760 · cited 1×
“For example, the levels of several detoxifying enzymes are reduced in AD brains compared with control cases (16–19); these changes are linked to a reduction in nuclear Nrf2 levels in AD brains compared with control cases (20).”
BackgroundFurukawa, M., & Xiong, Y. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.1.162-171.2005 · Cited by 746 · cited 1×
“Keap1 binds to Nrf2 in the cytoplasm and targets it for proteasomal degradation (7).”
BackgroundALLANBUTTERFIELD, D., CASTEGNA, A., LAUDERBACK, C., & DRAKE, J. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00340-2 · Cited by 715
Early Aβ accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain
Ingelsson, M., Fukumoto, H., Newell, K. L., Growdon, J. H., Hedley–Whyte, E. T., Frosch, M. P., Albert, M. S., Hyman, B. T., & Irizarry, M. C. (2004) · Neurology · doi:10.1212/01.wnl.0000115115.98960.37 · Cited by 666
Chen, P.-C., Vargas, M. R., Pani, A. K., Smeyne, R. J., Johnson, D. A., Kan, Y. W., & Johnson, J. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813361106 · Cited by 579 · cited 1×
“Notably, overexpression of Nrf2 in glia cells protected against MPTPmediated toxicity (29).”
BackgroundManoharan, S., Guillemin, G. J., Abiramasundari, R. S., Essa, M. M., Akbar, M., & Akbar, M. D. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/8590578 · Cited by 523 · cited 1×
“To this end, highly reactive oxygen species are another constant feature of AD (14,15).”
BackgroundHensley, K., Maidt, M. L., Yu, Z., Sang, H., Markesbery, W. R., & Floyd, R. A. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-20-08126.1998 · Cited by 507
Repression of the Antioxidant NRF2 Pathway in Premature Aging
Kubben, N., Zhang, W., Wang, L., Voss, T. C., Yang, J., Qu, J., Liu, G.-H., & Misteli, T. (2016) · Cell · doi:10.1016/j.cell.2016.05.017 · Cited by 489 · cited 1×
“ity decreases as a function of age (32,35).”
BackgroundThe Transcription Factor Nrf2 Is a Therapeutic Target against Brain Inflammation
Innamorato, N. G., Rojo, A. I., García-Yagüe, À. J., Yamamoto, M., de Ceballos, M. L., & Cuadrado, A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.1.680 · Cited by 480 · cited 2×
“Nrf2 and inflammation (28), the data presented here are consis-”
BackgroundGong, B., Vitolo, O. V., Trinchese, F., Liu, S., Shelanski, M., & Arancio, O. (2004) · Journal of Clinical Investigation · doi:10.1172/jci22831 · Cited by 442 · cited 1×
“contextual fear conditioning (48,49), while others have found”
BackgroundDeshmukh, P., Unni, S., Krishnappa, G., & Padmanabhan, B. (2017) · Biophysical Reviews · doi:10.1007/s12551-016-0244-4 · Cited by 398 · cited 1×
“The nuclear factor (erythroid-derived 2)-like 2 (Nrf2) is a transcription factor that regulates the expression of a vast number of genes by binding to the antioxidant response element (1,2).”
BackgroundReddy, P. H., Tripathi, R., Troung, Q., Tirumala, K., Reddy, T. P., Anekonda, V., Shirendeb, U. P., Calkins, M. J., Reddy, A. P., Mao, P., et al. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.10.011 · Cited by 394 · cited 1×
“To this end, highly reactive oxygen species are another constant feature of AD (14,15).”
BackgroundNRF2-regulation in brain health and disease: Implication of cerebral inflammation
Sandberg, M., Patil, J., D'Angelo, B., Weber, S. G., & Mallard, C. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.11.004 · Cited by 390 · cited 1×
“Nrf2 regulates brain inflammation by controlling the expression of several inflammatory markers (27).”
BackgroundNrf2 regulates microglial dynamics and neuroinflammation in experimental Parkinson's disease
Rojo, A. I., Innamorato, N. G., Martín‐Moreno, A. M., De Ceballos, M. L., Yamamoto, M., & Cuadrado, A. (2010) · Glia · doi:10.1002/glia.20947 · Cited by 375 · cited 1×
“nyl-1, 2, 3, 6-tetrahydropyridine (55).”
The Keap1 BTB/POZ dimerization function is required to sequester Nrf2 in cytoplasm
Zipper, L. M., & Mulcahy, R. T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206530200 · Cited by 366
Inflammation in Alzheimer’s disease: Lessons learned from microglia-depletion models
Spangenberg, E. E., & Green, K. N. (2017) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2016.07.003 · Cited by 352 · cited 1×
“the complex interaction between inflammation and Ab (68) and”
BackgroundPuzzo, D., Staniszewski, A., Deng, S. X., Privitera, L., Leznik, E., Liu, S., Zhang, H., Feng, Y., Palmeri, A., Landry, D. W., et al. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.0864-09.2009 · Cited by 331
Nrf2 reduces levels of phosphorylated tau protein by inducing autophagy adaptor protein NDP52
Jo, C., Gundemir, S., Pritchard, S., Jin, Y. N., Rahman, I., & Johnson, G. V. W. (2014) · Nature Communications · doi:10.1038/ncomms4496 · Cited by 323
Nrf2—a therapeutic target for the treatment of neurodegenerative diseases
Johnson, D. A., & Johnson, J. A. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.07.147 · Cited by 321 · cited 1×
“While Nrf2 is considered a master regulator of the cellular redox status, it also controls the expression of genes involved in the overall metabolic reprogramming during stress and inflammation (3,4).”
BackgroundMao, P., & Reddy, P. H. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.08.005 · Cited by 313 · cited 1×
“Evidence indicates that oxidative stress increases as a function of age in many organs, including the brain (12,13).”
BackgroundBLASKO, I., MARX, F., STEINER, E., HARTMANN, T., & GRUBECK‐LOEBENSTEIN, B. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.1.63 · Cited by 280
Hippocampus, amygdala, and memory deficits in rats
Sutherland, R. J., & McDonald, R. J. (1990) · Behavioural Brain Research · doi:10.1016/0166-4328(90)90072-m · Cited by 278 · cited 1×
“brain regions (31), indicating that the lack of Nrf2 has a global”
BackgroundThe ubiquitin‐proteasome system in Alzheimer's disease
Oddo, S. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00276.x · Cited by 264
Self-citationLastres-Becker, I., Ulusoy, A., Innamorato, N. G., Sahin, G., Rábano, A., Kirik, D., & Cuadrado, A. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds143 · Cited by 263
Blasko, I., Veerhuis, R., Stampfer-Kountchev, M., Saurwein-Teissl, M., Eikelenboom, P., & Grubeck-Loebenstein, B. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0321 · Cited by 258
Nuclear factor erythroid 2-related factor 2 protects against beta amyloid
Kanninen, K., Malm, T. M., Jyrkkänen, H.-K., Goldsteins, G., Keksa-Goldsteine, V., Tanila, H., Yamamoto, M., Ylä-Herttuala, S., Levonen, A.-L., & Koistinaho, J. (2008) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2008.07.010 · Cited by 255
Caccamo, A., Maldonado, M. A., Bokov, A. F., Majumder, S., & Oddo, S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012851108 · Cited by 249
Self-citationModulation of proteostasis by transcription factor NRF2 and impact in neurodegenerative diseases
Pajares, M., Cuadrado, A., & Rojo, A. I. (2017) · Redox Biology · doi:10.1016/j.redox.2017.01.006 · Cited by 220 · cited 1×
“The nuclear factor (erythroid-derived 2)-like 2 (Nrf2) is a transcription factor that regulates the expression of a vast number of genes by binding to the antioxidant response element (1,2).”
BackgroundCuadrado-Tejedor, M., Hervias, I., Ricobaraza, A., Puerta, E., Pérez-Roldán, J., García-Barroso, C., Franco, R., Aguirre, N., & García-Osta, A. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01517.x · Cited by 209
Autophagic/lysosomal dysfunction in Alzheimer’s disease
Orr, M. E., & Oddo, S. (2013) · Alzheimer's Research & Therapy · doi:10.1186/alzrt217 · Cited by 199
Self-citationOxidative stress involving changes in Nrf2 and ER stress in early stages of Alzheimer's disease
Mota, S. I., Costa, R. O., Ferreira, I. L., Santana, I., Caldeira, G. L., Padovano, C., Fonseca, A. C., Baldeiras, I., Cunha, C., Letra, L., et al. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.03.015 · Cited by 183 · cited 1×
“Nrf2 plays a key role in oxidative stress response (11,24).”
BackgroundJoshi, G., Gan, K. A., Johnson, D. A., & Johnson, J. A. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.09.004 · Cited by 175
Type I interferon pathway in CNS homeostasis and neurological disorders
Blank, T., & Prinz, M. (2017) · Glia · doi:10.1002/glia.23154 · Cited by 165
Abbas, N., Bednar, I., Mix, E., Marie, S., Paterson, D., Ljungberg, A., Morris, C., Winblad, B., Nordberg, A., & Zhu, J. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00050-4 · Cited by 161
Fractalkine activates NRF2/NFE2L2 and heme oxygenase 1 to restrain tauopathy-induced microgliosis
Lastres-Becker, I., Innamorato, N. G., Jaworski, T., Rábano, A., Kügler, S., Van Leuven, F., & Cuadrado, A. (2014) · Brain · doi:10.1093/brain/awt323 · Cited by 160
Wu, W., Li, Y., Wu, Y., Zhang, Y., Wang, Z., & Liu, X. (2015) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500109 · Cited by 134
Vitamin D, reactive oxygen species and calcium signalling in ageing and disease
Berridge, M. J. (2016) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2015.0434 · Cited by 127 · cited 1×
“Evidence indicates that oxidative stress increases as a function of age in many organs, including the brain (12,13).”
BackgroundMaes, M. H. J., Devos, N., Wauters, A., Demedts, P., Maurits, V., Neels, H. M., Bosmans, E., Altamura, C. A., Lin, A., Song, C., et al. (1999) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(99)00016-3 · Cited by 112
Xu, H., Gelyana, E., Rajsombath, M., Yang, T., Li, S., & Selkoe, D. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.1023-16.2016 · Cited by 109
An Overview of Genome-Wide Association Studies in Alzheimer’s Disease
Shen, L., & Jia, J. (2016) · Neuroscience Bulletin · doi:10.1007/s12264-016-0011-3 · Cited by 106 · cited 1×
“Genetically, genome-wide association data have consistently highlighted a link between AD and genes associated with the inflammatory response (26).”
BackgroundCaccamo, A., Branca, C., Talboom, J. S., Shaw, D. M., Turner, D., Ma, L., Messina, A., Huang, Z., Wu, J., & Oddo, S. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.2781-15.2015 · Cited by 105 · cited 1×
“The MWM is commonly used to evaluate spatial learning and memory, and it was performed as previously described (70).”
MethodSelf-citationMastrangelo, M. A., Sudol, K. L., Narrow, W. C., & Bowers, W. J. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.090059 · Cited by 100
Lee, M., McGeer, E. G., & McGeer, P. L. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.07.024 · Cited by 93
Validation of a 2-day water maze protocol in mice
Gulinello, M., Gertner, M., Mendoza, G., Schoenfeld, B. P., Oddo, S., LaFerla, F., Choi, C. H., McBride, S. M. J., & Faber, D. S. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.09.002 · Cited by 83 · cited 1×
“We performed the task as previously described (71,72), and measured two different kinds of errors: incorrect arm entries (reference memory errors) and re-entries (working memory errors) for day one and day two.”
MethodSelf-citationNovel behavioural characteristics of the APPSwe/PS1ΔE9 transgenic mouse model of Alzheimer's disease
Cheng, D., Logge, W., Low, J. K., Garner, B., & Karl, T. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.02.008 · Cited by 82
Orr, M. E., Salinas, A., Buffenstein, R., & Oddo, S. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.12.006 · Cited by 75
Self-citationAN IMBALANCE BETWEEN PRO- AND ANTI-INFLAMMATORY CYTOKINES, A CHARACTERISTIC FEATURE OF OLD AGE
Saurwein-Teissl, M., Blasko, I., Zisterer, K., Neuman, B., Lang, B., & Grubeck-Loebenstein, B. (2000) · Cytokine · doi:10.1006/cyto.2000.0679 · Cited by 69
Zhu, M., Allard, J. S., Zhang, Y., Perez, E., Spangler, E. L., Becker, K. G., & Rapp, P. R. (2014) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000060 · Cited by 68
Alzheimer's disease: Innate immunity gone awry?
VanItallie, T. B. (2017) · Metabolism · doi:10.1016/j.metabol.2017.01.014 · Cited by 67
Neophobia, NQO1 and SIRT1 as premorbid and prodromal indicators of AD in 3xTg-AD mice
Torres–Lista, V., Parrado‐Fernández, C., Alvarez-Montón, I., Frontiñán-Rubio, J., Durán‐Prado, M., Peinado, J. R., Johansson, B. A., Alcain, F. J., & Giménez‐Llort, L. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.04.055 · Cited by 63
Branca, C., Wisely, E. V., Hartman, L. K., Caccamo, A., & Oddo, S. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.06.011 · Cited by 63
Self-citationJayasooriya, R. G. P. T., Lee, K.-T., Lee, H., Choi, Y. H., Jeong, J.-W., & Kim, G. (2013) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.12.011 · Cited by 57
Medina, D. X., Orr, M. E., & Oddo, S. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.07.006 · Cited by 53 · cited 1×
“The contextual fear conditioning (CFC) test was performed using an apparatus from San Diego Instruments (CA, USA) as previously described (73).”
MethodSelf-citationWeekman, E. M., Sudduth, T. L., Abner, E. L., Popa, G. J., Mendenhall, M. D., Brothers, H. M., Braun, K., Greenstein, A., & Wilcock, D. M. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-127 · Cited by 49
Glial Activation in AβPP/PS1 Mice is Associated with Infiltration of IFNγ-Producing Cells
Kelly, R. J., Minogue, A. M., Lyons, A., Jones, R. S., Browne, T. C., Costello, D. A., Denieffe, S., O'Sullivan, C., Connor, T. J., & Lynch, M. A. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-130539 · Cited by 47
Caccamo, A., Majumder, S., & Oddo, S. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.09.022 · Cited by 45
Self-citationRustay, N. R., Cronin, E. A., Curzon, P., Markosyan, S., Bitner, R. S., Ellis, T. A., Waring, J. F., Decker, M. W., Rueter, L. E., & Browman, K. E. (2009) · Brain Research · doi:10.1016/j.brainres.2009.11.040 · Cited by 43
Pim1 inhibition as a novel therapeutic strategy for Alzheimer’s disease
Velazquez, R., Shaw, D. M., Caccamo, A., & Oddo, S. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0118-z · Cited by 39
Self-citationCaccamo, A., Medina, D. X., & Oddo, S. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.3314-12.2013 · Cited by 38 · cited 1×
“We processed the tissue as previously described (74).”
MethodSelf-citationJackson, H. M., Onos, K. D., Pepper, K. W., Graham, L. C., Akeson, E. C., Byers, C., Reinholdt, L. G., Frankel, W. N., & Howell, G. R. (2015) · PLOS ONE · doi:10.1371/journal.pone.0125897 · Cited by 32
Influence of Genetic Background on Apathy-Like Behavior in Triple Transgenic AD Mice
Pardossi‐Piquard, R., Lauritzen, I., Bauer, C., Sacco, G., Robert, P. H., & Checler, F. (2016) · Current Alzheimer Research · doi:10.2174/1567205013666160404120106 · Cited by 31
Strain specific differences in memory and neuropathology in a mouse model of Alzheimer's disease
Glazner, K. A. C., Odero, G. L., Anema, E., Motnenko, A., Schapansky, J., Grossman, D., Oliver, D. R., Glazner, G. W., & Albensi, B. C. (2010) · Life Sciences · doi:10.1016/j.lfs.2010.04.014 · Cited by 29
Xing, S., Shen, D., Chen, C., WANG, J., & Yu, Z. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2252 · Cited by 25 · cited 1×
“This finding is not consistent with a recent report showing an increase in HO-1 levels in APP/PS1 mice (30).”
ResultPark, S., Ko, H., Lee, N., Lee, H., Rim, E. Y., Kim, H., Lee, K., & Kaang, B. (2010) · Genes & Genomics · doi:10.1007/s13258-010-0833-8 · Cited by 7
Cited by
Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease
Butterfield, D. A., & Halliwell, B. (2019) · Nature Reviews Neuroscience · doi:10.1038/s41583-019-0132-6 · Cited by 1,954
Redox metabolism: ROS as specific molecular regulators of cell signaling and function
Lennicke, C., & Cochemé, H. M. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.08.018 · Cited by 1,246
Tu, W., Wang, H., Li, S., Liu, Q., & Sha, H. (2019) · Aging and disease · doi:10.14336/ad.2018.0513 · Cited by 707
“clear link between Nrf2 and AD-mediated cognitive decline, thus further strengthening the connection between Nrf2 and AD [134].”
BackgroundRedox Signaling by Reactive Electrophiles and Oxidants
Parvez, S., Long, M. J. C., Poganik, J. R., & Aye, Y. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00698 · Cited by 359
NRF2 as a Therapeutic Target in Neurodegenerative Diseases
Brandes, M. S., & Gray, N. E. (2020) · ASN Neuro · doi:10.1177/1759091419899782 · Cited by 297
“Similarly, in transgenic mouse models of AD, loss of NRF2 has been shown to increase levels of Ab and phosphorylated tau (Branca et al., 2017; Rojo et al., 2017); increase glial activation, markers of oxidative stress, and neurodegeneration; and exacerbate cognitive decline (Rojo et al., 2017; Rojo…”
BackgroundInfluential
Metadata
- Authors
- Branca, C., Ferreira, E., Nguyen, T.-V., Doyle, K., Caccamo, A., & Oddo, S.
- Affiliations
- Arizona State University (US)
- University of Arizona (US)
- Corresponding author
- Oddo, Salvatore
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-09-19
- Volume
- 26
- Issue
- 24
- Pages
- 4823-4835
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- PMC
- PMC5886066
- OpenAlex
- W2754019401
- Cited by
- 139
- References
- 78
- Citations by year
- 2026: 9 · 2025: 26 · 2024: 23 · 2023: 18 · 2022: 19 · 2021: 11 · 2020: 15 · 2019: 10 · 2018: 8
- FWCI
- 6.68
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Human Molecular Genetics (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (R01 AG037637)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Nrf2, Alzheimer's disease, cognitive impairment, APP/PS1 mice, spatial learning and memory, working memory, associative memory, amyloid-beta, interferon-gamma, microglial activation, aging, neurodegeneration, antioxidant response element
- MeSH terms
- Alzheimer Disease, Animals, Brain, Cognition Disorders, Disease Models, Animal, Female, Male, Memory Disorders, Mice, Transgenic, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, NF-E2-Related Factor 2, Mice, Presenilin-1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.